PRSG – Pharmaceutical and Regulatory Services GmbH – is a company that offers comprehensive services for all aspects of regulatory affairs in means of a One-Stop-Shop.
Niconex Medical Ltd, a private company in the Republic of Cyprus with SME status granted by the European Medicines Agency (EMA) is dedicated to advancing healthcare solutions by delivering professional support in Regulatory Affairs, local Pharmacovigilance, local Market entry and product maintenance.
DRA Consulting Oy is a Finnish pharmaceutical consultancy company operating Europe-wide. We operate in co-operation with more than 200 pharmaceutical companies. We are known for our high quality, flexible and efficient services. Our vision is to be a pioneering, well-known and successful global provider of pharmaceutical expertise. We will take our clients to the destination via the quickest route.
PharOS is a pharmaceutical company which develops, registers and supplies high quality generic pharmaceutical products, by thoroughly selecting molecules and strategic partners. Already one of the fastest growing generic companies in Europe, PharOS aims to provide products that improve the lives of patients worldwide and satisfy customer needs.
With 13 years of experience, PharSolution has a deep knowledge of regulatory affairs, including pricing and reimbursement, and Pharmacovigilance, as a consequence of its partnerships developed with different institutions, such as national companies, multinationals, as well as strong relationships with the representative official institutions of the health sector in Portugal.
MediSanus d.o.o. is a private Slovenian company established in 2002. MediSanus d.o.o. is offering consultation and management of marketing authorisations, price applications, reimbursements, pharmacovigilance, marketing and tender support.
By concentrating exclusively on regulatory affairs, we can offer in-depth knowledge, insight, skills, and experience in the field of medicinal products, medical devices, cosmetics, food supplements, biocides.
Member under assessment.